Gil Blum
Stock Analyst at Needham
(2.16)
# 2,703
Out of 4,863 analysts
389
Total ratings
36.78%
Success rate
-3.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Buy | $125 → $50 | $21.56 | +131.91% | 32 | Jun 16, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.02 | +395.05% | 28 | Jun 12, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $43.49 | +86.25% | 22 | May 20, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $12.43 | +133.28% | 16 | May 15, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $1.92 | +837.50% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.81 | +220.28% | 4 | May 14, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $63.66 | +64.94% | 23 | Dec 10, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.29 | - | 8 | Jun 12, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $8 | $2.61 | +206.51% | 28 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Downgrades: Hold | $42 | $2.80 | +1,400.00% | 21 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.84 | +443.48% | 17 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.80 | +150.00% | 18 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $10.46 | +282.47% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.40 | +1,894.02% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $4.92 | +62.77% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $11.60 | +132.76% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.59 | +117.86% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.60 | +462.50% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.50 | +60.32% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.99 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.48 | +238.98% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.87 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.48 | +738.05% | 9 | Aug 2, 2024 |
Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125 → $50
Current: $21.56
Upside: +131.91%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
CRISPR Therapeutics AG
May 20, 2025
Reiterates: Buy
Price Target: $81
Current: $43.49
Upside: +86.25%
Celcuity
May 15, 2025
Reiterates: Buy
Price Target: $29
Current: $12.43
Upside: +133.28%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $1.92
Upside: +837.50%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.81
Upside: +220.28%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $63.66
Upside: +64.94%
Fate Therapeutics
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.29
Upside: -
Taysha Gene Therapies
Jun 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.61
Upside: +206.51%
Rocket Pharmaceuticals
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $2.80
Upside: +1,400.00%
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.84
Upside: +443.48%
May 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $10.46
Upside: +282.47%
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.40
Upside: +1,894.02%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $4.92
Upside: +62.77%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $11.60
Upside: +132.76%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.59
Upside: +117.86%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $2.50
Upside: +60.32%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.99
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.48
Upside: +238.98%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.87
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.48
Upside: +738.05%